Cytokinetics, Inc. (CYTK)

62.16 -1.19 (-1.88%) USD  |  NASDAQ  |  Dec 15, 16:00
62.16 0.00 (0.00%) After-Hours: 20:00
More

Cytokinetics Research and Development Expense (TTM): 395.61M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Jasper Therapeutics, Inc. 71.52M
Bristol Myers Squibb Co. 9.719B
Lantheus Holdings, Inc. 165.15M
Pfizer Inc. 10.13B
Fortrea Holdings, Inc. --